Our Mission

The International Neoadjuvant Melanoma Consortium (INMC) was established in order to bring together key stakeholders across multiple disciplines including medical oncology, surgical oncology, pathology, radiology, and translational research from institutions around the world with the goal of creating an organized approach into the investigation of neoadjuvant treatment in melanoma.

 Through this mechanism and with a comprehensive approach to maximizing collaborative opportunities amongst investigators and institutions, the INMC seeks to advance treatment for patients with melanoma.